Sleep Timing and Energy Balance

NCT ID: NCT01866280

Last Updated: 2015-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-11-30

Study Completion Date

2013-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to test the effects of sleep and meal timing, independent of sleep duration, on glucose regulation and metabolic and hormonal control of energy balance in normal weight adults.

This study will be a 4-phase, randomized controlled study of 5 days each in which participants will undergo 2 phases of late sleep times that differ in meal timing (normal or late) and 2 phases of normal sleep times that differ in meal timing (normal or late).

The Aims and Hypotheses of this study are:

Aim 1: To compare hormonal regulation of food intake and metabolic risk markers in response to altered sleep and meal timing.

* Hypothesis 1: There will be an interaction between sleep and meal time on glucose, insulin, and glucose and insulin area under the curve after the glucose tolerance test such that the late sleep/late meal will result in the worst metabolic profile, normal sleep/late meal and late sleep/normal meal will have an intermediate profile, and normal sleep/normal meal will result in the best metabolic profile.
* Hypothesis 2: There will be an interaction between sleep and meal time on leptin and ghrelin concentrations such that the late sleep/late meal timing phase will result in low leptin/high ghrelin, normal sleep/late meal timing and late sleep/normal meal will have an intermediate profile, and normal sleep/normal meal timing will result in high leptin/low ghrelin.

Aim 2: To compare food intake over a 24-h period in response to altered sleep and meal timing.

• Hypothesis 3: Energy and fat intakes will be greater during the late sleep timing phase compared to normal sleep timing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Meals

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal sleep Normal meals

Normal sleep/Normal meal times

Group Type EXPERIMENTAL

Normal sleep

Intervention Type BEHAVIORAL

Normal sleep= sleep 2300-0700

Normal meals

Intervention Type BEHAVIORAL

Normal meal times=approximately 1.5, 5, and 11 h after wake up for breakfast, lunch, and dinner, and snack at 13 h after wake up time

Normal sleep Late meals

Normal sleep/Late meal times

Group Type EXPERIMENTAL

Normal sleep

Intervention Type BEHAVIORAL

Normal sleep= sleep 2300-0700

Late meals

Intervention Type BEHAVIORAL

Late meal times= approximately 4.5, 7, and 13 h after wake up time for breakfast, lunch and dinner, and snack at 15 h.

Late sleep Late meals

Late sleep/Late meal times

Group Type EXPERIMENTAL

Late sleep

Intervention Type BEHAVIORAL

Late sleep=sleep at 0230-1030 hours

Late meals

Intervention Type BEHAVIORAL

Late meal times= approximately 4.5, 7, and 13 h after wake up time for breakfast, lunch and dinner, and snack at 15 h.

Late sleep Normal meals

Late sleep/Normal meal times

Group Type EXPERIMENTAL

Normal meals

Intervention Type BEHAVIORAL

Normal meal times=approximately 1.5, 5, and 11 h after wake up for breakfast, lunch, and dinner, and snack at 13 h after wake up time

Late sleep

Intervention Type BEHAVIORAL

Late sleep=sleep at 0230-1030 hours

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Normal sleep

Normal sleep= sleep 2300-0700

Intervention Type BEHAVIORAL

Normal meals

Normal meal times=approximately 1.5, 5, and 11 h after wake up for breakfast, lunch, and dinner, and snack at 13 h after wake up time

Intervention Type BEHAVIORAL

Late sleep

Late sleep=sleep at 0230-1030 hours

Intervention Type BEHAVIORAL

Late meals

Late meal times= approximately 4.5, 7, and 13 h after wake up time for breakfast, lunch and dinner, and snack at 15 h.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Body mass index 22-25
* Normal scores on sleep questionnaires (PSQI, ESS, Berlin, SDIQ)
* Normal score on Beck Depression Inventory
* Intermediate chronotype on Composite Scale of Morningness/Eveningness

Exclusion Criteria

* Neurological, medical, or psychiatric disorders
* Eating disorders
* Diabetes
* Sleep disorders
* Travel across time zones
* History of drug/alcohol abuse
* Caffeine intake \>300 mg/d
* Excessive daytime sleepiness
* Pregnancy or within 1 y post-partum
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Luke's-Roosevelt Hospital Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Luke's/Roosevelt Hospital

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ST-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sleep and Metabolism
NCT05775627 RECRUITING NA
Home Sleep and Metabolism
NCT02253368 COMPLETED NA